ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,494Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 324

$580K Total Retail Price of All Prescriptions

Rank: 74 out of 324

354 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 354 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,449 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 530 421 1 2
AMLODIPINE BESYLATE 433 411 2 4
HYDROCODONE-ACETAMINOPHEN 410 286 S3 3 5
SIMVASTATIN 317 265 4 1
LISINOPRIL 264 229 5 3
METFORMIN HCL 247 190 6 9
ATENOLOL 237 233 7 18
WARFARIN SODIUM 232 224 8 10
FUROSEMIDE 216 165 9 7
OMEPRAZOLE 215 177 10 6
GABAPENTIN 213 149 11 13
POTASSIUM CHLORIDE 205 174 12 8
HYDROCHLOROTHIAZIDE 160 128 13 11
LOVASTATIN 145 138 14 43
CITALOPRAM HBR 140 125 15 16
LANTUS 134 110 16 39
ALENDRONATE SODIUM 125 125 17 24
TRAMADOL HCL 122 121 18 19
METOPROLOL SUCCINATE 122 100 18 17
DONEPEZIL HCL 116 116 20 25
GLIMEPIRIDE 113 102 21 37
NOVOLOG 101 82 22 60
ZOLPIDEM TARTRATE 99 77 23 20
CARVEDILOL 96 82 24 22
PREDNISONE 91 73 25 36
NAMENDA 89 89 26 31
FLUTICASONE PROPIONATE 89 76 26 32
PAROXETINE HCL 88 54 28 72
LOSARTAN POTASSIUM 85 72 29 15
PANTOPRAZOLE SODIUM 84 74 30 34
CLOPIDOGREL 81 74 31 38
KLOR-CON M20 79 53 32 52
POLYETHYLENE GLYCOL 3350 78 59 33 49
METOPROLOL TARTRATE 75 75 34 14
ROPINIROLE HCL 75 67 34 87
MECLIZINE HCL 72 56 36 234
ATORVASTATIN CALCIUM 71 67 37 12
PLAVIX 69 65 38 63
GEMFIBROZIL 68 48 39 93
PROAIR HFA 68 46 39 50
GLYBURIDE 67 67 R 41 59
SPIRIVA 67 65 41 70
FENTANYL 65 42 S2 43 64
JANUVIA 65 62 43 83
JANUMET 64 29 45 239
METHOTREXATE 64 64 45 168
AMITRIPTYLINE HCL 64 45 R 45 66
NEXIUM 63 28 48 33
MELOXICAM 62 52 49 29
FAMOTIDINE 61 41 50 62
RANITIDINE HCL 61 59 50 58
SPIRONOLACTONE 59 47 52 47
PREMARIN 59 55 R 52 122
LOSARTAN-HYDROCHLOROTHIAZIDE 58 55 54 44
LACTULOSE 57 55 55 172
DILTIAZEM 24HR CD 57 45 55 81
SERTRALINE HCL 57 57 55 23
EVISTA 55 53 58 116
ALLOPURINOL 54 20 59 27
CYMBALTA 53 41 60 45
CIPROFLOXACIN HCL 53 46 60 55
ADVAIR DISKUS 52 44 62 61
DILTIAZEM ER 52 52 62 128
ENALAPRIL MALEATE 51 42 64 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 40 65 91
DOXAZOSIN MESYLATE 50 40 65 76
VENLAFAXINE HCL 50 50 65 187
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.